Literature DB >> 17336738

Value of insulin-like growth factor system markers in the assessment of growth hormone status.

David R Clemmons1.   

Abstract

Insulin-like growth factor-I (IGF-I) has been measured extensively in a variety of clinical settings. Total IGF-I frequently is used to assess the clinical impact of disorders of GH secretion and to monitor patients' response to therapy. It does not have sufficient precision to be used as a stand-alone test in the diagnosis of GH deficiency. Free IGF-I, IGF binding protein-3, or acid-labile subunit may provide useful information regarding GH secretion in specific conditions but are not superior to IGF-I for making the diagnosis of GH deficiency or acromegaly.

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17336738     DOI： 10.1016/j.ecl.2006.11.008

Source DB:  PubMed          Journal:  Endocrinol Metab Clin North Am        ISSN： 0889-8529            Impact factor:   4.741


  16 in total

1.  Plasma Agouti-Related Protein Levels in Acromegaly and Effects of Surgical or Pegvisomant Therapy.

Authors:  Pamela U Freda; Carlos Reyes-Vidal; Zhezhen Jin; Mya Pugh; Sunil K Panigrahi; Jeffrey N Bruce; Sharon L Wardlaw
Journal:  J Clin Endocrinol Metab       Date:  2019-11-01       Impact factor: 5.958

2.  Hypothalamic leptin gene therapy reduces body weight without accelerating age-related bone loss.

Authors:  Russell T Turner; Michael Dube; Adam J Branscum; Carmen P Wong; Dawn A Olson; Xiaoying Zhong; Mercedes F Kweh; Iske V Larkin; Thomas J Wronski; Clifford J Rosen; Satya P Kalra; Urszula T Iwaniec
Journal:  J Endocrinol       Date:  2015-10-20       Impact factor: 4.286

3.  A novel neutralizing antibody targeting pregnancy-associated plasma protein-a inhibits ovarian cancer growth and ascites accumulation in patient mouse tumorgrafts.

Authors:  Marc A Becker; Paul Haluska; Laurie K Bale; Claus Oxvig; Cheryl A Conover
Journal:  Mol Cancer Ther       Date:  2015-02-18       Impact factor: 6.261

4.  Predicting the probability of abnormal stimulated growth hormone response in children after radiotherapy for brain tumors.

Authors:  Chiaho Hua; Shengjie Wu; Wassim Chemaitilly; Renin C Lukose; Thomas E Merchant
Journal:  Int J Radiat Oncol Biol Phys       Date:  2012-04-06       Impact factor: 7.038

Review 5.  The current status of IGF-I assays--a 2009 update.

Authors:  Jan Frystyk; Pamela Freda; David R Clemmons
Journal:  Growth Horm IGF Res       Date:  2009-10-08       Impact factor: 2.372

Review 6.  Discordance between growth hormone and insulin-like growth factor-1 after pituitary surgery for acromegaly: a stepwise approach and management.

Authors:  Mehdi Zeinalizadeh; Zohreh Habibi; Juan C Fernandez-Miranda; Paul A Gardner; Steven P Hodak; Sue M Challinor
Journal:  Pituitary       Date:  2015-02       Impact factor: 4.107

Review 7.  Current Insights into the Role of the Growth Hormone-Insulin-Like Growth Factor System in Short Children Born Small for Gestational Age.

Authors:  Judith S Renes; Jaap van Doorn; Anita C S Hokken-Koelega
Journal:  Horm Res Paediatr       Date:  2019-09-11       Impact factor: 2.852

8.  Diagnosing growth hormone deficiency in adults.

Authors:  Nigel Glynn; Amar Agha
Journal:  Int J Endocrinol       Date:  2012-07-26       Impact factor: 3.257

9.  Downregulation of Signaling-active IGF-1 by Dipeptidyl Peptidase IV (DPP-IV).

Authors:  Ching-Ting Lin; Hsiang-Yun Tang; Yu-San Han; Hui-Ping Liu; Shiu-Feng Huang; Chia-Hui Chien; John Shyy; Jeng-Jian Chiu; Xin Chen
Journal:  Int J Biomed Sci       Date:  2010-12

10.  Plasma IGFBP-2 levels after postoperative combined radiotherapy and chemotherapy predict prognosis in elderly glioblastoma patients.

Authors:  Sheng Han; Lingxuan Meng; Shuai Han; Yunjie Wang; Anhua Wu
Journal:  PLoS One       Date:  2014-04-01       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.